Kairos Pharma, Ltd. Balance Sheet
Kairos Pharma, Ltd.'s total assets for Q4 2025 were $6.54M, a decrease of -18.92% from the previous quarter. KAPA total liabilities were $199.00K for the fiscal quarter, a -50.50% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.